Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
复制标题

DOI:
10.1136/bmj.f2032
复制
发表时间:
2013-04-18
影响因子:
105.7
通讯作者:
Guy, Rebecca J.
Guy, Rebecca J.
中科院分区:
医学1区
文献类型:
--
作者:
Ali, Hammad;Donovan, Basil;Guy, Rebecca J.

文献摘要

被引文献

相似文献

目的评估2007年中期开始的澳大利亚国家人乳头瘤病毒疫苗接种计划对生殖器疣的影响。两个最大的诊所还收集了自2009年以来自我报告的人乳头瘤病毒疫苗接种状况。参与者在2004年至2011年期间,85770名澳大利亚出生的患者首次就诊; 7686(9.0%)被发现患有生殖器疣。主要结果指标率比比较在疫苗接种前诊断为患有生殖器疣的新患者比例的趋势(2004年至2007年年中)和疫苗接种期结果2007年中至2011年底,21岁以下人群比例下降幅度较大2011年,21-30岁女性(92.6%)和21-30岁女性(72.6%)在接种期间被诊断患有生殖器疣,从2007年的11.5%降至0.85%(P
Objective To measure the effect on genital warts of the national human papillomavirus vaccination programme in Australia, which started in mid-2007.Design Trend analysis of national surveillance data.Setting Data collated from eight sexual health services from 2004 to 2011; the two largest clinics also collected self reported human papillomavirus vaccination status from 2009.Participants Between 2004 and 2011, 85 770 Australian born patients were seen for the first time; 7686 (9.0%) were found to have genital warts.Main outcome measure Rate ratios comparing trends in proportion of new patients diagnosed as having genital warts in the pre-vaccination period (2004 to mid-2007) and vaccination period (mid-2007 to the end of 2011).Results Large declines occurred in the proportions of under 21 year old (92.6%) and 21-30 year old (72.6%) women diagnosed as having genital warts in the vaccination period-from 11.5% in 2007 to 0.85% in 2011 (P